Martin Shkreli Accused of Breaking Lifetime Pharma Ban Again

The FTC and a group of states said Martin Shkreli, the former pharmaceutical executive known as the "Pharma Bro," violated a lifetime ban from the pharmaceutical industry. The allegation centers on his continued public commentary on biopharma stocks, activity regulators say the ban was meant to prevent. Shkreli was barred from the industry following a prior price-gouging case tied to his former company. The new allegations suggest regulators are treating stock commentary, not just corporate roles, as a form of industry participation covered by the ban. It is not yet clear what specific penalty the FTC and states are seeking, or which biopharma names Shkreli's commentary targeted.